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Abstract
AIM: To evaluate published trials examining oral post-
operative protein supplementation in patients having 
undergone gastrointestinal surgery and assessment of 
reported results.
METHODS: Database searches (MEDLINE, BIOSIS, 
EMBASE, Cochrane Trials, Cinahl, and CAB), searches 
of reference lists of relevant papers, and expert referral 
were used to identify prospective randomized controlled 
clinical trials. The following terms were used to locate 
articles: “oral’’ or “enteral’’ and “postoperative care’’ 
or “post-surgical’’ and “proteins’’ or “milk proteins’’ or 
“dietary proteins’’ or “dietary supplements’’ or “nutritional 
supplements’’. In databases that allowed added 
limitations, results were limited to clinical trials that 
studied humans, and publications between 1990 and 
2014. Quality of collated studies was evaluated using 
a qualitative assessment tool and the collective results 
interpreted.
RESULTS: Searches identified 629 papers of which, 
following review, 7 were deemed eligible for qualitative 
evaluation. Protein supplementation does not appear 
to affect mortality but does reduce weight loss, and 
improve nutritional status. Reduction in grip strength 
deterioration was observed in a majority of studies, and 
approximately half of the studies described reduced 
complication rates. No changes in duration of hospital 
stay or plasma protein levels were reported. There is 
evidence to suggest that protein supplementation should 
be routinely provided post-operatively to this population. 
However, despite comprehensive searches, clinical trials 
that varied only the amount of protein provided via  oral 
nutritional supplements (discrete from other nutritional 
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components) were not found. At present, there is some 
evidence to support routinely prescribed oral nutritional 
supplements that contain protein for gastrointestinal 
surgery patients in the immediate post-operative stage.
CONCLUSION: The optimal level of protein supplemen-
tation required to maximise recovery in gastrointestinal 
surgery patients is effectively unknown, and may warr-
ant further study. 
Key words: Protein supplementation; Gastrointestinal 
surgery; Clinical trial; Oral supplementation; Systematic 
review
© The Author(s) 2016. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Malnutrition in hospitalized patients can nega-
tively impact recovery; protein and energy deficiencies 
have been documented in gastrointestinal surgery 
patients and trials have demonstrated benefits of peri-
operative nutritional strategies, although post-operative 
oral nutritional supplementation have been studied 
to a lesser extent. The outcome of our work is that 
clinical trials that varied only the protein provided via  
oral supplements were not found. There is evidence to 
support oral protein supplements for gastrointestinal 
surgery patients immediately post-operatively. But the 
optimal level of protein supplementation required to 
maximise recovery in gastrointestinal surgery patients is 
effectively unknown, and may warrant further study. 
Crickmer M, Dunne CP, O’Regan A, Coffey JC, Dunne SS. 
Benefits of post-operative oral protein supplementation in 
gastrointestinal surgery patients: A systematic review of clinical 
trials. World J Gastrointest Surg 2016; 8(7): 521-532  Available 
from: URL: http://www.wjgnet.com/1948-9366/full/v8/i7/521.
htm  DOI: http://dx.doi.org/10.4240/wjgs.v8.i7.521
INTRODUCTION
Malnutrition has been associated with increased incidence 
of complications such as sepsis, pneumonia, wound 
infections, clotting disorders, and wound dehiscence[1,2]. 
Patients undergoing major gastrointestinal surgery 
can suffer periods of undernourishment, not only as a 
consequence of their presenting illness, but also due to 
reduced food intake and the resulting catabolic state that 
prevails in the post-operative period. In this population, 
malnutrition has been found to increase post-operative 
morbidity and mortality rates as well as the duration 
and subsequent cost of hospital stay[3,4]. These despite 
multimodal nutritional regimens, include pre-operative 
carbohydrate loading.
In this context, nutritional supplementation has 
been suggested as a routine post-operative procedure 
for gastrointestinal surgery patients given the putative 
negative nitrogen balance. Indeed, intervention in 
the form of post-operative protein supplementation 
(in the context of allowable free-fluids or light diet by 
mouth) has remained of interest as an effective way to 
improve patient recovery despite an apparent paucity 
of trials adequately addressing the optimum, or even 
appropriate, quantity of proteins or peptides. As the 
physiological nitrogen balance is affected by both en-
ergy and protein consumption, knowledge of the levels 
of each that best enable avoidance of catabolic loss 
after gastrointestinal surgery could benefit patient 
outcomes[5]. 
Therefore, in this review, clinical trials of oral 
nutritional supplements providing increased protein 
levels relative to controls, administered to human 
patients recovering from gastrointestinal surgery, were 
systematically assessed with respect to clinical efficacy 
and cost-effectiveness. 
MATERIALS AND METHODS
Search methods
The following terms were used to locate articles: “oral’’ 
or “enteral’’ and “postoperative care’’ or “post-surgical’’ 
and “proteins’’ or “milk proteins’’ or “dietary proteins’’ 
or “dietary supplements’’ or “nutritional supplements’’. 
In databases that allowed added limitations, results 
were limited to clinical trials that studied humans, and 
publications between 1990 and 2014. Despite these 
limits, multiple non-clinical trial results, non-human trials, 
and irrelevant studies appeared and were excluded. The 
search was intentionally broad as more specific searches 
for gastrointestinal surgery associated keywords and 
MeSH terms resulted in numerous missed relevant 
papers. Databases searched included: MEDLINE, Biosis, 
EMBASE, Cochrane Trials, Cinahl, and CAB. Other means 
of identifying records included searching reference lists 
of relevant papers.
Inclusion and exclusion criteria 
Randomized controlled clinical trials examining protein-
based oral dietary supplementation post-operatively in 
human gastrointestinal surgery patients were selected. 
Studies were excluded if: Involved immunonutrition; 
related to supplementation with incomplete proteins; 
did not specify the amount of protein supplemented; 
supplemented patients pre-operatively only; not strictly 
oral nutrition; or not published in English. 
Outcomes measured
Primary outcomes included the effect of supplementation 
on post-operative complications, length of hospital stay, 
nutritional status, and weight loss. Secondary outcomes 
included the effect on plasma proteins, quality of life, 
function, and cost of care.
Data collection and analysis
Trials that met the inclusion criteria were independently 
assessed for eligibility by the authors (Crickmer M, O’
Regan A, Dunne CP) and discrepancies were resolved 
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by discussion. Papers were read independently by 
the authors and themes were identified. Risk of bias 
was assessed by determining allocation concealment 
for participants, the staff and assessors. The effect of 
treatment was assessed relative to clinical importance 
and statistical significance, using P values of ≤ 0.05 as 
the cut-off point. The evaluation of the trials was guided 
thematically with the qualitative tool, modified from a 
previous Cochrane Systematic Review[6], described in 
Tables 1 and 2. The characteristics of each study were 
tabulated and are shown in Table 3. 
Where studies included both pre-and post-operative 
supplementation interventions, only the post-operative 
components are considered in this review. The numbers 
of trial participants per study were adjusted to reflect 
this.
RESULTS
Results of the search
Following PRISMA guidelines[7], seven eligible reports 
were identified (see Figure 1). Exclusions were as 
follows: (1) of records found via database searching: 
358; (2) of records found by other means: 271; (3) 
of records screened: 629; (4) of records excluded 
(including removal of duplicates): 587; (5) of full text 
articles assessed for eligibility: 42; (6) of full text articles 
excluded: 35; and (7) of studies included in qualitative 
analysis: 7.
Assessment of studies design
All seven studies[5,8-13] were prospective randomized 
controlled trials. In most cases, the patients, their 
carers and the assessors were not blinded. Intention 
to treat was not included in most studies. The control 
and intervention groups had similar characteristics in 
each trial and in all other aspects of treatment, other 
than the intervention. The interventions undertaken, 
and inclusion and exclusion criteria, were well defined 
in all studies. Five of the seven studies[5,8,9,11,13] included 
outpatient phases that lasted between one and six 
months. The characteristics of the studies are outlined 
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Items and scores
Was the assigned treatment adequately concealed prior to allocation?
   2 = method did not allow disclosure of assignment 
   1 = small but possible chance of disclosure of assignment or states random but no description
   0 = quasi-randomized
Were the outcomes of participants who withdrew described and included in the analysis (intention to treat)?
   2 = intention-to-treat analysis based on all cases randomized possible or carried out
   1 = states number and reasons for withdrawal but intention-to-treat analysis not possible
   0 = not mentioned or not possible
Were the outcome assessors blinded to treatment status?
   2 = action taken to blind assessors, or outcomes such that bias is unlikely
   1 = small or moderate chance of unblinding of assessors
   0 = not mentioned
Were the treatment and control group comparable at entry?
   2 = good comparability of groups
   1 = confounding small
   0 = large potential for confounding, or not discussed
Were care programs, other than the trial options, identical?
   2 = care programs clearly identical
   1 = clear but unimportant differences
   0 = not mentioned or clear and important differences in care programs
Were the inclusion and exclusion criteria clearly defined?
   2 = clearly defined
   1 = inadequately defined
   0 = not defined
Were the interventions clearly defined (including estimates of nutritional value)?
   2 = clearly defined interventions are applied with a standardized protocol
   1 = clearly defined interventions are applied but the application protocol is not standardized
   0 = intervention and/or application protocol are poorly or not defined
Were the participants blind to assignment status following allocation?
   2 = effective action taken to blind participants
   1 = small or moderate chance of unblinding participants
   0 = not possible, or not mentioned (unless double-blind), or possible but not done
Were the treatment providers blind to assignment status?
   2 = effective action taken to blind treatment providers
   1 = small or moderate chance of unblinding of treatment providers
   0 = not possible, or not mentioned (unless double-blind), or possible but not done
Was the overall duration of surveillance clinically appropriate?
   2 = optimal (six months or more)
   1 = adequate (one up to six months)
   0 = not defined, or not adequate
Table 1  Quality assessment tool (adapted from[6])
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Overall nutritional intake: Four of the studies quan-
tified the difference in protein intake between treatment 
and CGs. Specifically, Saluja et al[10] found that protein 
intake was significantly higher (P < 0.01) in the group 
given supplementation in addition to ward diet. The TG 
consumed an average of 55.71 ± 11.63 g of protein per 
day during the study period, while the CG consumed 
39.48 ± 11.14 g of protein per day (P < 0.01). These 
increases in protein consumption were accompanied 
by significant increases in the amount of carbohydrate 
consumed (P < 0.01). Jensen et al[5] calculated that the 
TG consumed 22% more protein than the CG and 16% 
more energy. It is noteworthy that supplementation in 
that trial started after discharge at about day 10, and 
was paired with dietetic advice, while in the previous 
trial by Saluja et al[10], supplementation began the first 
day following surgery. Keele et al[11] also found that the 
TG showed statistically significant increases in protein 
and energy consumption on study days one to four. 
No difference in protein intake was seen in the second 
phase of their trial, which examined intake for 4 mo 
following discharge. The inpatient results (improved 
overall nutritional intake) found by Rana et al[12] are 
similar to those found by Keele et al[11].
Weight: Four of five studies that measured this 
factor[5,8,11,12] found reduced weight loss in normonouri-
shed patients receiving supplementation. Keele et 
al[11] found decreased loss both at day 3 of the trial 
and at discharge (P < 0.001). Rana et al[12] found that 
when patients started supplements as soon as they 
were allowed free fluids after surgery, they maintained 
their weight whereas by day 3, there was significant 
weight loss in the CG (P < 0.05). Statistically significant 
reduction in weight loss was also found by Smedley 
in Table 3.
Sample sizes and patient population
Sample sizes ranged from 40 to 101. A total of 529 
patients were involved, 262 of whom had an interven-
tion. Participants were post-operative gastrointestinal 
surgery patients scheduled for acute or elective surgery. 
Nutritional status pre-operatively was variable, with 
some studies focused on malnourished patients[10,13]. 
Patient age ranged from 18 to greater than 75, and all 
studies included both genders. 
Interventions 
All treatment group (TG) patients received post-oper-
ative nutritional supplementation in addition to their 
normal ward diet, while control groups (CGs) consumed 
only normal ward diet. In most cases, patients were 
encouraged to drink 200-400 mL of the supplement 
per day. Supplements comprised between 0.0078 g/
mL and 0.06 g/mL of protein, with the most frequent 
value being 0.05 g/mL. They also provided between 
0.6 kcal/mL and 1.5 kcal/mL of energy, with the most 
common inclusion being 1.5 kcal/mL. All studies, except 
Jensen[5], began supplementation as soon as allowed 
by the surgical team, typically beginning one to six 
days post-operatively. Some studies focused on post-
operative feeding only, while studies by Smedley et 
al[8] and MacFie et al[9] examined both pre-operative 
and post-operative feeding. Only the post-operative 
component of those studies is considered in this review 
and the numbers of trial participants has been adjusted 
to reflect this.
Themes
Assessment was according to the following eight themes:
July 27, 2016|Volume 8|Issue 7|WJGS|www.wjgnet.com
Smedley et al [8] Saluja et al [10] Beattie et al [13] MacFie et al [9] Jensen et al [5] Keele et al [11] Rana et al [12]
Was the treatment adequately 
concealed prior to allocation?
2 0 2 0 0 0 2
Were candidates who withdrew 
included in analysis?
0 No 
withdrawals
0 0 0 0 1
Were the assessors blinded? 0 0 0 0 2 0
Were treatment and control 
groups comparable at entry?
2 2 0 2 1 2 2
Specific mention of 
“lack of detail on 
patients at entry”
Specific mention 
of error “in the 
randomisation 
process”
Were care programmes 
otherwise identical?
2 2 2 2 2 2 2
Were the inclusion and exclusion 
criteria clearly defined?
2 2 2 2 2 2 2
Were the interventions clearly 
defined?
2 2 2 1 1 2 2
Were the participants blind to 
assignment after allocation?
0 0 0 0 0 0 0
Were the treatment providers 
blinded to allocation status?
0 0 0 0 0 0 0
Was duration of surveillance 
appropriate? 
1 1 2 2 1 1 0
Table 2  Outcomes of quality assessment, described for individual trials
Crickmer M et al . Post-operative oral protein supplementation: Systematic review of trials
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Ref. Method Participants Intervention Outcomes Conclusions/Notes
Smedley 
et al[8]
RCT Undergoing elective 
moderate-major lower GI 
surgery n = 89; 39 patients 
were controls in the pre-op 
phase and in the TG in phase 
2 making them the treatment 
group for this analysis. 
Fifty patients were controls 
throughout making them the 
control group
Included multiple groups with 
patients receiving pre and post-
operative supplementation. This 
review focused on the group that 
received no supplements pre- and 
post-op, as well as the group that 
received no supplement pre-op 
and supplements post-operation 
(CG = Group 4, TG = Group 3)
Complications: Fewer minor 
complications in TG (P < 0.05)
The patients in this 
study had a baseline 
of good nutritional 
intake
Supplementation began when 
patients allowed light diet or free 
fluids post-operation.
Length of stay: No difference
Fortisip, nutricia used as 
supplement: 0.05 g/mL protein, 
1.5 kcal/mL energy 
Weight loss: Significant reduction 
in patients given ONS before and 
after surgery and in patients given 
postoperative ONS only
TG asked to drink as they desired 
in addition to meals
Quality of life: No difference (Short 
Form 36, EuroQol instruments were 
used)
Cost: Reduced by GBP£300 (15%) 
per patient, however not statistically 
significant
Post-surgery oral nutritional 
supplements were of benefit 
independently of nutritional status
Saluja et 
al[10]
PRCT n = 60 (30/30) divided into 
BM, MM and SM using the 
NRI[26]
0.033 g/mL of protein or 16.66 
g/500 mL drink and 500 kcal 
energy, in addition to ward diet. 
Ward diet only was provided to 
control group. Trial started once 
surgical team allowed fluids or 
light diet
Adverse events: ONS well tolerated Severely 
malnourished 
patients have 
increased energy 
requirements and 
less oral intake, and 
will therefore lose 
lean body mass as a 
substrate for energy
Age: Between 20-60 yr Total protein intake: Increased in TG 
(P < 0.01)
Albumin half-life is 
20 d - early post-op 
period is too short 
to demonstrate a 
difference due to 
supplementation
Elective and emergency 
abdominal procedures (not 
just GI)
Voluntary protein intake higher 
though not significant
Treatment started from day-1 
post-operatively
Weight loss: TG = 2.15 kg vs CG = 4.6 
kg (P < 0.01)
Assessment was done on 
admission, day 3 and at 
discharge
Overall weight loss: TG = 5.6%, 
CG = 6.4%
Severely Malnourished Patients: 
TG = 6.3%, CG = 10% (P < 0.01)
No significant change in lymphocyte 
count
Complications: No significant 
difference
Length of stay: Statistically 
significant reduction in severely 
malnourished patients. No 
difference in other categories in 
length of stay
No change in mid arm circumference
No change in hand grip strength
Treatment group felt better 
than control group (subjective 
assessment)
No difference in voluntary intake in 
group consuming supplements
Table 3  Summary details of eligible trials
Crickmer M et al . Post-operative oral protein supplementation: Systematic review of trials
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Beattie et 
al[13]
PRCT Patients had a BMI < 20 or 
> 5% weight loss between 
hospital admission and 
trial inclusion, and other 
anthropometric criteria.
Oral nutritional supplement 
containing 0.06 g/mL protein, 
1.5 kcal/mL energy. Patients 
encouraged to consume 
400 mL/d postoperatively. In 
practice, patients had between 
200 and 400 mL/d in addition to 
normal meals
Weight loss: CG lost an average 
maximum of 5.96 kg at 8 wk 
after admission, while TG lost a 
maximum of 3.4 kg on average 
in the first 4 wk and then gained 
weight (P < 0.001)
Support for 
nutritional 
intervention in 
patients with 
malnutrition:
Age: 18-80 Mean body weight loss = 9.8% in 
CG and 5.6% in treatment group
Post-operative 
oral nutritional 
supplementation 
improved nutritional 
status, quality of life 
and morbidity
n = 101, intervention = 52; 
control = 49
Triceps skin fold and MAMC were 
higher in TG than CG (P < 0.001)
Function: Improved grip strength at 
10 wk (P < 0.001)
Quality of life (UK SF-36): 
Statistically significant improvement 
in mental and physical health (P < 
0.001)
Complications: Reduced (P < 0.05)
No difference in infection rates
Length of stay: No difference
MacFie 
et al[9]
PRCT Major GI surgery patients n 
= 52; 27 had intervention of 
some kind. 
TG n = 27 (post op 
supplements), CG n = 25
Pre and post-operative phases. 
For this review, only the control 
group and post-operative 
supplementation group were 
looked at
Nutritional intake: Increased protein 
and energy seen (but no benefits 
could be seen)
Similar intakes of 
supplements as 
previous trials (Rana, 
Keele) that showed 
benefit
Fortisip, Nutricia given - 0.05 g/
mL protein and 1.5 kcal energy/
mL or an alternative Fortijuice, 
Nutricia containing 0.025 g/mL 
protein and 1.25 kcal/mL energy. 
Patients encouraged to consume 
400 mL/d in addition to normal 
ward diet
Morbidity: No difference Also concluded: No 
difference in benefit 
when looked at the 
17 malnourished 
patients in the study
Supplementation commenced 
as soon as permitted fluids post-
surgery, usually within 24 h
Mortality: No difference Possible lack of 
difference due to 
small study numbers 
in each group, or 
in general, early 
return to eating post-
surgery in practice 
along with dietician 
support normally at 
the hospital
CG was provided standard ward 
diet
Effect on voluntary food intake: No 
difference
Nutritional status: No difference
Functional status: No difference
Hospital stay: No difference
Weight Loss: No significant 
difference
Serum albumin: No significant 
difference
Psychological Status: No significant 
differences
Return to normal activities at 6 mo: 
No difference
No evidence that increased 
supplements decreased amount of 
ward diet eaten
Jensen 
and 
Hessov[5]
RCT - 
Supplements 
given after 
discharge 
from colorectal 
surgery for 4 mo
Elective and acute n = 87: 47 
in CG and 40 in TG
Control group: Discharged 
without advice
Body mass: (50 d after discharge) 
lean body mass increase seen in 
TG of 1.3 kg (P = 0.009) and in 
overall body mass 2.0 kg (P = 
0.005). 110 d after discharge: Total 
mass difference was +2.7 kg for TG 
relative to CG (P = 0.014), and lean 
body mass +1.4 kg for TG (P = 0.029) 
No significant difference in fat mass 
was seen at either stage
Initially patients 
in the intervention 
group gained LBM 
without fat mass; 
later there were 
gains in both types 
of mass
TG: Dietetic advice and a variety 
of supplements including protein 
only - aiming for 1.5 g protein/kg 
per day
Serum albumin: No difference was 
seen at any time
Recommendation: 
Patients should 
increase protein 
intake to 1.5 g/kg 
per day for 2 mo 
post-surgery
Crickmer M et al . Post-operative oral protein supplementation: Systematic review of trials
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Keele et 
al[11]
Short and long 
term (4 mo 
after discharge) 
benefits of 
intervention
n = 100 moderate-major 
elective GI surgery; n = 53 in 
CG and n = 47 in TG.
TG was given oral nutritional 
supplement post-operatively in 
addition to ward diet, which was 
given to the control group
Inpatient phase Phase 1 assessment 
was at day 3 and 
discharge
In-patient and out-patient phases 
(to 4 mo after discharge)
Nutrient intake: Significant increase 
in protein and energy intake 
increase at days 1 and 2 (P < 0.001) 
and 3 (energy P < 0.01, protein P < 
0.001), day 4 (P < 0.05) and day 7 - 
protein only (P < 0.05)
Clinically 
significant benefits 
with short term 
supplementation 
but not long term 
supplementation
(There were 
four groups 
in this study: 
C/C had no 
supplementation 
before/after 
surgery; C/S had 
none before and 
supplementation 
after; S/C had 
supplementation 
before and none 
after; S/S had 
supplementation 
before and after 
surgery
Supplement consumption was “ad 
libitum”
No significant difference in intake of 
energy or protein from ward diet
Both CG and TG had 
below requirement 
levels of protein as 
in-patients
For the purposes 
of the review 
C/C were taken 
as CG and C/S 
were taken as 
TG)
Supplements - 200 mL cartons 
of Fortisip with 1.5 kcal and 0.05 
g/mL (10 g protein/carton)
Energy intake 1 m after discharge: 
Significantly higher in TG
By 1 mo, patients 
in both groups 
were eating well so 
supplements had 
little effect on well-
being
Weight loss: Less in treatment group 
at day 3 and discharge (P < 0.001)
The rapidity of the 
effects of protein 
supplementation 
suggests that its 
effect is due to a 
direct action of key 
nutrients rather than 
repletion of tissue 
stores
Serious complications: Less in 
treatment group (P < 0.05)
Handgrip: Significant reduction in 
CG at days 3 and 7; strength lost 
at day 3 in treatment group but 
regained by discharge 
Subjective fatigue: Increased fatigue 
in CG at day 3 and discharge (P < 
0.001), no significant increase in 
fatigue in TG
Complications: More in control 
group (P < 0.05)
Giving food did not reduce 
voluntary food intake
Outpatient phase
Nutrient Intake: No significant 
difference in protein intake in the 
out-patient phase. Significantly 
higher energy intake was seen 
(P < 0.05) in groups consuming 
supplements post-discharge 
compared to controls
No benefit was seen with 
supplementation post-discharge
Crickmer M et al . Post-operative oral protein supplementation: Systematic review of trials
528
et al[8] (P < 0.05). In the trial by Jensen et al[5], supple-
mentation was not started before discharge, typically 
around 10 d post-operatively, but at both 50 and 110 
d after discharge, the intervention group had increased 
total and lean body mass. No other studies looked 
specifically at lean body mass. Conversely, however, 
MacFie et al[9] reported no significant difference in weight 
loss between control and intervention groups overall.
Studies by Saluja et al[10] and Beattie et al[13] 
noted reduced weight loss in the malnourished pati-
ent population investigated in their studies, but no 
difference was seen by MacFie et al[9] when he isolated 
the 17 malnourished patients from his study. More 
specifically, Beattie et al[13] found that controls lost an 
average of 5.96 kg in 8 wk, while intervention patients 
lost 3.4 kg on average in the first 4 wk and then gained 
weight (P < 0.001). Saluja et al[10] quantified the 
average weight loss in the TG as 2.15 kg compared to 4.6 
kg in the CG (P < 0.01). 
Postoperative complications: None of the studies 
found a difference in mortality between control and 
TGs. A wide variety of other complications were looked 
at including chest and wound infection, sepsis, cardiac 
arrest, pulmonary embolism, and wound dehiscence. 
Three of the 6 trials that investigated complications 
found a reduced number in the TG: Smedley et al[8] 
found reduced minor complications (P < 0.05) but no 
difference in major complications. Both Keele et al[11] 
and Rana et al[12] demonstrated significantly fewer 
serious complications in their short term studies (P < 
0.05). No difference in post operative complications 
was found by Saluja et al[10] or MacFie et al[9]. Saluja et 
al[10] did find a reduction in infectious complications in 
severely malnourished patients, but numbers were too 
small for statistical significance. Similarly, Beattie et al[13] 
saw a reduction in complications that was not significant 
when adjusting for age and sex. 
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Rana et 
al[12]
Short term 
only: Started 
on day patients 
could receive 
free fluids until 
discharge
n = 40; 20 control and 20 
supplemented
Ad libitum supplementation 
with oral nutritional sip feed in 
addition to control diet
Nutritional intake: significantly 
higher energy intake in the 
treatment group P < 0.004 (as well 
as the nutritional value of the 
supplements, more energy was 
consumed from ward diet by these 
patients) and protein intake (due 
solely to supplements)
In the CG there is a 
significant protein 
deficit by day 3 
which persisted to 
day 7 (often the day 
of discharge)
Major G-I surgery 7.8 g/L unhydrolysed protein. 
1.5 kcal/mL energy density. 1.4 L 
is needed to provide all required 
nutrient as defined by United 
Kingdom health board
Significant weight loss in CG but not 
TG at day 3 and discharge
5-6 d on average 
elapsed between 
day of operation 
and day 1 of study 
period where diet 
was allowed. Study 
period began when 
surgical team 
allowed “free-fluids 
or light diet”
Controls and given ward diet and 
allowed snacks
Grip strength difference at day 3 
and discharge (P < 0.03) in favor of 
treatment group
Within 3 d of “free 
fluids/light diet” 
treatment patients 
were consuming 70 g 
protein/d and about 
2000 kcal
No difference in mid-arm 
circumference/triceps skin folds 
changes between groups
Observed increased 
number of calories 
(not protein) 
being eaten from 
ward diet in the 
treatment group 
- inference that 
supplementation 
helped to maintain 
appetite
Serious complications (pneumonia, 
wound infection) significantly 
higher in CG
No difference in length of stay
Complications: Pneumonia and 
wound infection seen. P < 0.02 in 
favor of treatment group
Blood proteins: No difference in 
serum albumin, retinol binding 
albumin, prealbumin. Significant 
difference in retinol binding protein 
as CG declined while TG levels 
remained same. P < 0.05
Hospital stay length: No statistically 
significant difference
TG: Treatment group; CG: Control group; RCT: Randomised controlled trial; PRCT: Prospective randomised controlled trial; ONS: Oral nutritional 
supplement; MAMC: Mid-arm muscle circumference; LBM: Lean body mass; BM: Borderline malnourished; MM: Moderately malnourished; SM: Severely 
malnourished; NRI: Nutritional risk index.
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Length of stay: The study by Saluja et al[10] determined 
a difference in length of stay between treatment and 
CGs in severely malnourished patients, but no difference 
in moderately or borderline malnourished patients. 
Beattie’s study[13], which also looked at malnourished 
patients, found no difference. The three studies[8,12,13] 
that evaluated length of stay in normonourished patients 
found no difference.
Plasma proteins: Four studies investigated plasma 
proteins levels[5,9,10,12], with albumin the focus of most 
of these studies. None of these found any significant 
difference in serum albumin or prealbumin. Rana et 
al[12] found increased retinol binding protein in the TG 
relative to controls at day three (P < 0.05).
Cost: Smedley et al[8] found that the use of oral nutriti-
onal supplementation, irrespective of when administered, 
decreased cost by £300 (sterling) per patient amounting 
to a 15% reduction compared to patients without 
supplementation. This was not statistically significant. 
No other study considered cost of care.
Grip strength: Three of five studies that investigated 
grip strength found reduced loss of grip strength in 
patients receiving oral nutritional supplements relative 
to controls. Keele et al[11] found that handgrip was 
maintained in the intervention group and significantly 
reduced in controls (P < 0.01). Rana et al[12] found a 
significant difference at day three and again at discharge 
(P < 0.05). Beattie et al[13] found similar results and 
noted statistical significance in the differences at 
week 10 (P < 0.001). Saluja et al[10] and MacFie et 
al[9] detected no difference in hand grip strength after 
supplementation. 
Quality of life and fatigue: Beattie et al[13] found 
increased quality of life in the TG using the short form 
36 questionnaire (SF-36)[14] in both mental and physical 
health (P < 0.001). Smedley et al[8] used SF-36 and 
EuroQol instruments to test quality of life and found no 
difference. Keele et al[11] subjectively assessed fatigue 
and found significant increases in control patients at 
study day three (P < 0.001), while TG increases in 
fatigue were not significant. 
DISCUSSION
Previous reviews have concluded that oral nutritional 
supplements can have positive effects in terms of 
recovery of nutritional status post-operatively in 
conditions such as fractured neck of femur, colorectal 
surgery, and pancreaticoduodenectomy, among 
others[15-17]. In these cases, the proposed benefits 
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Medline, cinahl, biosis, embase, CAB
1990-2012
355 citation (s)
Other means
1990-2012
271 citation (s)
Cochrane
1990-2012
3 citation (s)
587 non-duplicate
citations screened
42 articles retrieved
545 articles excluded
after title/abstract screen
32 articles excluded 
after full text screen
3 articles excluded 
during data extraction
7 articles included
Inclusion/exclusion
criteria applied
Inclusion/exclusion
critcria applied
Figure 1  PRISMA guidelines.
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could be attributed to protein supplementation (i.e., 
the amount of orally-consumed protein that confers the 
greatest benefit) combined with appropriate energy 
intake[18]. However, what these levels are remain unclear 
for patients following gastrointestinal surgery. In this 
review, we attempted to determine this via systematic 
review. 
Our searches did not yield a single randomized 
controlled trial that adequately differentiated the 
effect of protein supplementation from carbohydrate 
supplementation. Therefore, analysis of the eligible 
reports was problematic. Limitations included the fact 
that protein and energy content in TG supplements 
were not equivalent in most of the studies. Indeed, 
only the study by Saluja et al[10] described using a 
fixed amount of supplement for daily consumption, 
while the remaining studies followed an “ad-libitum” 
approach. Arguably, the latter approach best mirrors 
“real-life” clinical scenarios, however it makes discerning 
the true effect of protein supplementation difficult. 
Furthermore, the characteristics of the patient cohorts 
were not equivalent between studies, confounding 
inter-study comparisons. For example, the study by 
Saluja et al[10] took place in Delhi and included a greater 
proportion of emergency surgery patients, and patients 
with tuberculosis, compared with the non-emergent 
procedures described in the Western European reports. 
Moreover, inadequate follow up time with control and 
TGs was common across studies, with some risk of bias 
associated with lack of blinding of participants, carers 
and assessors. The power of the studies was often too 
small, with one author conceding notably that “numbers 
were too small for meaningful statistical analysis”[13] 
and intention to treat analysis was not used in any 
of the studies. Finally, the most recent of the eligible 
trials found in our searches was published in 2004, 
arguably reflecting either a shift in interest away from 
oral intake in favor of enteral and parenteral nutrition in 
this population or an emphasis placed on ordinary diet 
without supplement.
Despite these limitations, the authors of six of the 
seven studies detailed weight loss in patients recei-
ving post-operative nutritional supplements, but to a 
lesser degree than the loss in control patients[5,8,10-13]. 
In fact, the data suggest that this effect may be 
most prominent in patients malnourished initially, 
with statistically significant reductions in weight loss 
observed. While one study failed to observe this effect[9], 
despite similar energy and protein intakes to other 
trials, the authors proposed that the lack of effect was 
due to a small sample size. Finally, with respect to 
weight gain post-operatively, it appears that weight 
gain commenced sooner and patients appeared to 
return to their preoperative weight more rapidly where 
supplementation was provided. 
There is no evidence to suggest that nutritional 
supplementation post-operatively reduces mortality. 
While more deaths did occur in the CGs of the reported 
trials, much larger samples would be needed to 
approach statistical significance. The topic of avoidance 
of both serious and minor complications is less clear. 
There is some precedent to suggest that post-operative 
supplementation decreases complications, as the 
effect has been documented in patients undergoing 
hip surgery[15,19,20]. However, across the eligible studies 
here, the rate of both serious and minor complications 
was significantly reduced in four of the trials[8,11-13], while 
no statistically significant difference was observed in 
two[9,10]. This variation has been addressed somewhat by 
Beattie et al[13] when comparing his results to the study 
by MacFie et al[9] in making reference to discrepancies 
in defining complications. On a related topic, duration 
of hospitalization was reduced significantly in severely 
malnourished patients only[10]. An additional study 
that supplemented increased amounts of protein and 
medium chain carbohydrates in enteral feed in gastroin-
testinal patients post-operatively found a 6-d reduction 
on average (P < 0.05)[21]. However, that study had 
larger numbers than any of the studies considered in 
this review, with 229 total and 115 TG patients. It has 
also been suggested that length of stay is a relatively 
poor outcome to evaluate as it often depends on patient 
social circumstances and services available in addition to 
patient post-operative clinical condition[12].
With respect to malnutrition, and assessment of 
patient incidence, low albumin has been used as a 
measurable indicator, but evidence suggests that it is 
not an effective marker of recent nutritional intake[22]. 
Approximately 5% of the circulating albumin is replaced 
daily by the liver and, therefore, any changes in protein 
intake would not be evident immediately. Further, protein 
markers in the blood such as prealbumin, albumin and 
transferrin are impacted by fluid shifts and responses 
to injury and inflammation which complicate their 
use in comparisons of patients before and after major 
abdominal surgery, when tissue injury is present[23]. This 
may explain why none of the studies in our review that 
monitored albumin in the early post-operative period 
found any disparity in albumin levels despite differences 
in anthropometric indicators of malnutrition (e.g., triceps 
skin fold, mid upper arm circumference and BMI[23]). 
Similarly inconsistent results were found regarding 
quality of life. 
Evaluation of quality of life and physiological function 
were similarly inconsistent. For example, handgrip 
strength is a marker of function and results were vari-
able across the trials. However, those variances may 
be explained by the use of dissimilar techniques for 
measurement, and confounders such as pain and fatigue 
post-operatively. Interestingly, the TGs in the studies 
conducted by MacFie et al[9] and Saluja et al[10] both 
described increased total body mass retention relative to 
CGs, but without significant increases in grip strength. 
Jensen et al[5] found that supplementation increased 
lean body mass particularly, not simply fat mass, so 
one could hypothesize that a functional measurement 
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like grip strength would also be improved, but this was 
not described. Previous work has documented a link 
between impaired muscle function and nutritionally-
related complications[24,25], but this was not consistently 
reflected across the eligible trials here. 
The seven studies reviewed in this paper concurred 
that there is no difference in mortality seen with 
protein-inclusive nutritional supplements. There is 
evidence to suggest that weight reduction, nutritional 
intake, and nutritional status are improved, and that 
there may be positive cost of hospitalisation benefits, 
but evidence as to the effect on complications and 
grip strength is mixed. At present, there is some 
evidence to support routinely prescribed oral nutritional 
supplements that contain protein for gastrointestinal 
surgery patients in the immediate post-operative stage. 
However, randomized control trials using well-designed 
methodology to examine the optimal protein content 
needed to confer benefit are needed.
COMMENTS
Background
Malnutrition in hospitalized patients can negatively impact recovery; protein 
and energy deficiencies have been documented in gastrointestinal surgery 
patients and trials have demonstrated benefits of perioperative nutritional 
strategies, although post-operative oral nutritional supplementation have been 
studied to a lesser extent. The proposed benefits may be attributed to protein 
supplementation (i.e., the amount of orally-consumed protein that confers the 
greatest benefit) combined with appropriate energy intake. However, what 
those levels may be remain unclear for gastrointestinal surgery patients. 
Research frontiers
The positive impact of pre-operative nutrition has been reviewed previously 
and meta-analyses have demonstrated positive influence on patient outcome 
following gastrointestinal surgery. In the postoperative period however, the most 
pertinent question may be whether patients should be further supplemented. 
The most recent of the eligible trials found in the searches was published in 
2004. 
Innovations and breakthroughs
The authors’ searches did not yield a single randomized controlled trial 
that adequately differentiated the effect of protein supplementation from 
carbohydrate supplementation. With only one exception, the eligible studies 
reviewed here involved post-operative supplements administered “ad-
libitum”. Although this may best mirror “real-life” clinical scenarios, it makes 
discerning the true effect of protein supplementation difficult. Furthermore, the 
characteristics of the patient cohorts were not equivalent between studies. 
Despite these limitations, the authors of six of the seven studies detailed weight 
loss in patients receiving post-operative nutritional supplements, but to a lesser 
degree than the loss in control patients. There is no evidence to suggest that 
nutritional supplementation post-operatively reduces mortality and evaluation of 
quality of life and physiological function were similarly inconsistent.
Applications
An intervention based on oral protein supplementation should be investigated 
through a double-blind randomized controlled trial.
Terminology
There are no terms used that are uncommon and that would be unfamiliar to 
readers.
Peer-review
The authors have made a good collation of the data to assess if there are 
any benefits of post-operative protein nutritional supplementation following 
gastrointestinal surgery. The manuscript is well written and covers the salient 
points from the published studies.
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